David C. Robbins, MD

Robbins is the Bud and Sally Cray Professor of Diabetes and director of the University of Kansas Diabetes Institute.

October 20, 2021

2 min read

Save

Authorized generic drugs ‘insufficient’ to improve affordability in Medicare Part D

Authorized generic drugs for insulin and direct-acting antiviral agents may lower out-of-pocket spending for patients but are unlikely to provide savings for Part D plans or Medicare, data show.

David C. Robbins, MD

Most recent by David C. Robbins, MD

Authorized generic drugs ‘insufficient’ to improve affordability in Medicare Part D